Article thumbnail

Prevalence and Patterns of Nitrosatable Drug Use among U.S. Women during Early Pregnancy

By Jean D Brender, Katherine E Kelley, Martha M Werler, Peter H Langlois, Lucina Suarez and Mark A Canfield
Topics: Original Article
Publisher: Wiley Subscription Services, Inc., A Wiley Company
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1984). Accuracy of spontaneous abortion recall.
  2. (2004). Dietary nitrites and nitrates, nitrosatable drugs, and neural tube defects.
  3. (2005). Disease Control and Prevention. The National Birth Defects Prevention Study Protocol. Revised 1/4/05,
  4. (1989). Drugs from the class of tricyclic antidepressives and antiepileptics, nitrosatable under simulated human gastric conditions. Arch Geschwulstforsch 59:257–263.
  5. (1983). Embryotoxicity induced by alkylating agents. Teratogenicity of acetoxymethyl-methylnitrosamine: dose-response relationship, application route dependency and phase specificity. Arch Toxicol 52:45–69.
  6. (2007). Epidemiology: beyond the basics.
  7. (1994). Experimental evidence for inhibition of N-nitroso compound formation as a factor in the negative correlation between vitamin C consumption and the incidence of certain cancers.
  8. (1985). Formation of DNA-damaging nitroso compounds by interaction of drugs with nitrite. A preliminary screening for detecting potentially hazardous drugs.
  9. (1984). Formation of volatile nitrosamines by drug-nitrite interactions under physiological conditions.
  10. (2003). Genotoxic activities of drug-nitrite interaction products. Drug Chem Toxicol 26:295–308.
  11. (2007). Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products.
  12. (1986). Identification of mutagenic nitrosation products of antipyrine and evaluation of their formation under model stomach conditions. Chem Pharm Bull (Tokyo)
  13. (2005). Maternal drug use, fertility problems, and infant craniostenosis.
  14. (1995). Maternal exposure to N-nitrosatable drugs as a risk factor for childhood brain tumors.
  15. (2001). Maternal exposure to nitrate from drinking water and diet and risk for neural tube defects.
  16. (1998). Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and craniosynostosis.
  17. (2004). Maternal medication use and neuroblastoma in offspring.
  18. (2006). Maternal medication use and the risk of brain tumors in the offspring: the SEARCH international case-control study.
  19. (2003). Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours.
  20. (1988). Mutagenicity of products generated by the reaction between several antiparasitic drugs and nitrite. Environ Mol Mutagen 12:65–73.
  21. (1982). N-nitroso compounds and childhood brain tumors: a case-control study.
  22. (2005). National Birth Defects Prevention Study.
  23. (1989). Nitrosatable drug exposure during pregnancy and adverse pregnancy outcome.
  24. (1980). Nitrosation and mutagenicity of some amine drugs.
  25. (1980). Nitrosation of orally administered drugs under simulated stomach conditions.
  26. (1984). Occurrence and exposure to N-nitroso compounds and precursors.
  27. (1974). Reaction of drugs with nitrous acid as a source of carcinogenic nitrosamines.
  28. (2004). Recall bias of the symptoms of nausea and vomiting of pregnancy.
  29. (1985). Susceptibilities of drugs to nitrosation under simulated gastric conditions. Food Chem Toxicol 23:849–855.
  30. (1984). Susceptibilities of drugs to nitrosation under standardized chemical conditions. Food Chem Toxicol 22:269–274.
  31. (2003). The Slone Drug Dictionary: a research driven pharmacoepidemiology tool. Pharmacoepidemiol Drug Saf 12:S168–S198.